EUVIMEDEUVIMED entdecken
Crossref

Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population‐based study

Hayato Tada iD, Hidehiro Kaneko iD, Yuta Suzuki, Akira Okada, Norifumi Takeda, Katsuhito Fujiu, Hiroyuki Morita, Junya Ako, Koichi Node, Yasuaki Takeji, Masayuki Takamura, Hideo Yasunaga und 1 weitere

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Hayato Tada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atrial Fibrillation, Hyperlipoproteinemia Type II, Atherosclerosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Familial hypercholesterolemia (FH) is associated with atherosclerotic cardiovascular disease (ASCVD). However, the prevalence of FH among a general population remains unknown, and it is unclear if FH is associated with other cardiovascular complications, including heart failure (HF) and atrial fibrillation (AF).

Methods

Analyses were conducted on individuals without a prior history of cardiovascular disease using a nationwide health claims database collected in the JMDC Claims Database between 2005 and 2022 ( n = 4,126,642; median age, 44 years; 57.5% men). We defined FH as either LDL cholesterol ≥250 mg/dL or LDL cholesterol ≥175 mg/dL under the lipid‐lowering medications under the assumption that lipid‐lowering medications reduced LDL cholesterol by 30%. We assessed the associations between FH and composite outcomes, including, ASCVD (myocardial infarction, angina pectoris, and stroke), HF, and AF using Cox proportional hazard model.

Results

We identified 11,983 (.29%) FH patients. In total, 181,150 events were recorded during the mean follow‐up period of 3.5 years. The status FH was significantly associated with composite outcomes after adjustments (hazard ratio [HR]; 1.38, 95% confidence interval [CI]: 1.30–1.47, p < .001). Interestingly, the status FH was significantly associated with HF (HR: 1.48, 95% CI: 1.36–1.61, p < .001) and AF (HR: 1.33, 95% CI: 1.08–1.64, p < .001) in addition to angina pectoris (HR: 1.45, 95% CI: 1.33–1.58, p < .001) and stroke (HR: 1.19, 95% CI: 1.04–1.36, p < .001).

Conclusion

We found that the prevalence of FH was .29% in a general population. FH was significantly associated with a higher risk of developing cardiovascular disease, HF and AF. Lay summary We sought to identify the prevalence of FH among a general population, and to clarify whether FH increases the risk of not only ASCVD but also HF and AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAtrial FibrillationHyperlipoproteinemia Type IIAtherosclerosisHeart FailureStrokeMaleHumansAdultFemaleCholesterol, LDLRisk FactorsAngina Pectoris

Stichwörter der Autor:innen

ASCVDLDL cholesterolatrial fibrillationcardiovascular diseasefamilial hypercholesterolemiaheart failure

Substanzen

Cholesterol, LDL

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • The Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
  • The Department of Advanced Cardiology, The University of Tokyo, Tokyo, Japan.
  • Center for Outcomes Research and Economic Evaluation for Health, National Institute of Public Health, Saitama, Japan.
  • Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Cardiovascular Medicine, Kitasato University School of Medicine, Kanagawa, Japan.

ORCID-Profile: Hayato Tada, Hidehiro Kaneko

Förderung

  • Ministry of Health, Labour and Welfare

Zitieren

APA

Tada, H., Kaneko, H., Suzuki, Y., Okada, A., Takeda, N., Fujiu, K., Morita, H., Ako, J., Node, K., Takeji, Y., Takamura, M., Yasunaga, H., & Komuro, I. (2024). Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population‐based study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14119

Vancouver

Tada H, Kaneko H, Suzuki Y, Okada A, Takeda N, Fujiu K, et al. Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population‐based study. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14119

BibTeX
@article{Tada2024,
  author = {Tada, Hayato and Kaneko, Hidehiro and Suzuki, Yuta and Okada, Akira and Takeda, Norifumi and Fujiu, Katsuhito and Morita, Hiroyuki and Ako, Junya and Node, Koichi and Takeji, Yasuaki and Takamura, Masayuki and Yasunaga, Hideo and Komuro, Issei},
  title = {Familial hypercholesterolemia is related to cardiovascular disease, heart failure and atrial fibrillation. Results from a population‐based study},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14119}
}
Kostenlos starten →